Clinicopathological effects of body composition measurements for patients with endometrial cancer

Minerva Ginecol. 2020 Dec;72(6):430-435. doi: 10.23736/S0026-4784.20.04629-8. Epub 2020 Jul 28.

Christopher G Smith¹, Deepti Sharma², Hagen Smith³, Shelley Zippay⁴, Liza Bastin⁵, Luis Acosta-Briceno⁶, James Lee⁷, Brent Shelton⁸, Justin Gorski^{2

9}, Anthony Mcdowell^{2

9}, Brian Burgess^{2

9}, Tricia Fredericks¹⁰, Rachel Miller^{2

9}, Christopher Desimone^{2

9}, Charles Dietrich^{2

9}, Holly Gallion^{2

9}, Frederick Ueland^{2

9}, Edward Pavlik^{2

9}, John Vannagell^{2

9}, Lauren Baldwin^{2

9}

¹ Division of Gynecologic Oncology, Department of Gynecology and Obstetrics, Emory University, Atlanta, GA, USA - christopher.smith2@emory.edu.
² Department of Obstetrics and Gynecology, University of Kentucky, Lexington, KY, USA.
³ Department of Obstetrics and Gynecology, TriHealth Good Samaritan Hospital, Cincinnati, OH, USA.
⁴ Department of Obstetrics and Gynecology, New Hanover Regional Medical Center, Wilmington, NC, USA.
⁵ Department of Internal Medicine, University of Kentucky, Lexington, KY, USA.
⁶ Department of Radiology, University of Kentucky, Lexington, KY, USA.
⁷ Emergency Radiology and Abdominal Radiology, University of Kentucky, Lexington, KY, USA.
⁸ Department of Biostatistics, Markey Cancer Center, University of Kentucky, Lexington, KY, USA.
⁹ Division of Gynecologic Oncology, Markey Cancer Center, Lexington, KY, USA.
¹⁰ Division of Gynecologic Oncology, Department of Obstetrics and Gynecology, University of Nebraska Medical Center, Omaha, NE, USA.

No abstract available

MeSH terms